Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors	Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, central nervous system cancer, digestive system neuroendocrine neoplasm, meningioma, neoplasm, nervous system disorder, neuroendocrine neoplasm, paraganglioma, pheochromocytoma, primitive neuroectodermal tumor, tumor of meninges, vascular cancer	Recruiting	Phase 1 / Phase 2	2026-05-14		NCT05636618

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Perspective Therapeutics	5

19 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
BAMF Health	Grand Rapids	United States	15
Barbara Ann Karmanos Cancer Institute	Detroit	United States	44
Biogenix Molecular	Miami	United States	2
Fred Hutchinson Cancer Center	Seattle	United States	250
Froedtert Medical College of Wisconsin	Milwaukee	United States	1
Johns Hopkins	Baltimore	United States	39
Mayo Clinic	Rochester	United States	664
Mayo Clinic	Jacksonville	United States	122
Michigan Health Professionals	Troy	United States	1
Nebraska Cancer Specialists	Omaha	United States	40
Ohio State University	Columbus	United States	169
The University of Chicago	Chicago	United States	65
UH Cleveland Medical Center	Cleveland	United States	13
University of Iowa	Iowa City	United States	284
University of Kentucky	Lexington	United States	98
University of North Carolina	Chapel Hill	United States	101
Vanderbilt-Ingram Cancer Center	Nashville	United States	48
Virginia Cancer Specialists	Fairfax	United States	109
Washington University	St Louis	United States	182